Dual-Biomarker Algorithm Can Inform Osteoarthritis Diagnosis
By Elana Gotkine HealthDay Reporter
THURSDAY, Dec. 19, 2024 -- A new diagnostic test using a dual-biomarker algorithm can inform osteoarthritis diagnosis with high accuracy, according to a study published online Dec. 18 in the Journal of Orthopaedic Research.
Daniel Keter, from CD Diagnostics in Claymont, Delaware, and colleagues developed a combinatorial algorithm using cartilage oligomeric matrix protein and interleukin-8 (IL-8) concentrations to differentiate primary osteoarthritis from inflammatory arthritis. A total of 171 human knee synovial fluid specimens were used to establish and validate clinical decision limits for cartilage oligomeric matrix protein concentration and the cartilage oligomeric matrix protein-to-IL-8 ratio.
The researchers found that clinical sensitivity and specificity were 87.0 and 88.9 percent, respectively, for the osteoarthritis algorithm, for overall accuracy of 88.3 percent. The osteoarthritis algorithm had an area under the curve of 0.93 in analysis of the receiver operating characteristic curve derived for the osteoarthritis algorithm ratios calculated on the primary osteoarthritis cohort versus the inflammatory arthritis cohort.
"Looking forward, differentiating primary osteoarthritis from other inflammatory arthritis types contributes towards better diagnosis that enables accurate, and targeted treatment of primary osteoarthritis," the authors write.
All authors are paid employees of CD Diagnostics or CD Laboratories, which are subsidiaries of Zimmer Biomet. Several authors disclosed financial ties to Zimmer Biomet, which funded the study.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Transcutaneous Auricular Vagus Nerve Stimulation May Aid Knee Pain
TUESDAY, May 27, 2025 -- Transcutaneous auricular vagus nerve stimulation (tVNS) may be a safe pain-relieving treatment for people with knee osteoarthritis (OA), according to a...
Residual Inflammation Seen in One-Third of Patients With Psoriasis on Biologics
WEDNESDAY, May 21, 2025 -- For patients with psoriasis receiving biologic therapy, residual inflammation (RI), defined as increased inflammatory markers in blood, characterized by...
Exposure to Certain HIV Drugs May Significantly Lower Risk for Alzheimer Disease
TUESDAY, May 20, 2025 -- Exposure to nucleoside reverse transcriptase inhibitors (NRTIs), which treat HIV and hepatitis B and inhibit inflammasome activation, is associated with a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.